Recent research focusing on Tirzepatide at a dosage of 30mg is shedding new light on its potential applications. Early findings suggest that this higher dosage may enhance the drug's ability to manage blood glucose, potentially offering greater outcomes for individuals with insulin resistance. Further investigation is underway to fully evaluate the… Read More